VEGFA and neoplasm: For example, the experiences obtained from these two phase I clinical trials will be very useful for the investigation of this VEGF-based vaccine in phase II clinical trials, where a larger number of patients with the same type of tumor will be included (Trial registration numbers: RPCEC00000237 and RPCEC00000246).